Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $6.30 million. The enterprise value is $5.50 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 15.18 million shares outstanding. The number of shares has increased by 27.54% in one year.
| Current Share Class | 15.18M |
| Shares Outstanding | 15.18M |
| Shares Change (YoY) | +27.54% |
| Shares Change (QoQ) | +5.36% |
| Owned by Insiders (%) | 22.83% |
| Owned by Institutions (%) | 11.43% |
| Float | 7.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 18.78 |
| P/TBV Ratio | 18.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.39.
| Current Ratio | 0.63 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -298.57% and return on invested capital (ROIC) is -184.12%.
| Return on Equity (ROE) | -298.57% |
| Return on Assets (ROA) | -123.09% |
| Return on Invested Capital (ROIC) | -184.12% |
| Return on Capital Employed (ROCE) | -3,494.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.14M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -91.52% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 2.67 |
| Relative Strength Index (RSI) | 17.91 |
| Average Volume (20 Days) | 482,530 |
Short Selling Information
The latest short interest is 174,784, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 174,784 |
| Short Previous Month | 41,542 |
| Short % of Shares Out | 1.15% |
| Short % of Float | 2.46% |
| Short Ratio (days to cover) | 0.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.24M |
| Pretax Income | -15.07M |
| Net Income | -15.01M |
| EBITDA | n/a |
| EBIT | -15.24M |
| Earnings Per Share (EPS) | -$1.05 |
Full Income StatementBalance Sheet
The company has $929,000 in cash and $131,000 in debt, giving a net cash position of $798,000 or $0.05 per share.
| Cash & Cash Equivalents | 929,000 |
| Total Debt | 131,000 |
| Net Cash | 798,000 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 334,000 |
| Book Value Per Share | 0.02 |
| Working Capital | -978,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |